Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Joshua Wechsler

Pediatric Gastroenterology Chicago, IL Medical Doctor

NPI 1912109596 CMS profile 1243019

2515 N Clark St, Chicago, IL 60614

Open in the dashboard

General payments

$432,980

281 records reported · program years 2020–2025

Research payments

$1,705

Paid to them · 3 records reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Wechsler of Chicago, IL is reported in the CMS Open Payments database as having received $432,980 across 281 general payments and $1,705 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $97,771 54
2025 Research $1,705 3
2024 General $184,720 86
2023 General $61,724 76
2022 General $79,406 60
2021 General $6,168 4
2020 General $3,191 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Wechsler
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Joshua Wechsler were reported at $97,771. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Joshua Wechsler Pediatric Gastroenterology median Middle half National median
2019 $0 $131 $41–$311 $163
2020 $3,191 $79 $23–$223 $114
2021 $6,168 $104 $32–$321 $132
2022 $79,406 $125 $37–$331 $149
2023 $61,724 $169 $55–$440 $160
2024 $184,720 $196 $73–$563 $164
2025 $97,771 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Genzyme Corporation $206,734 91 payments
  2. Regeneron Healthcare Solutions, Inc. $178,655 148 payments
  3. AstraZeneca Pharmaceuticals LP $16,436 8 payments
  4. AstraZeneca UK Limited $11,009 4 payments
  5. Regeneron Pharmaceuticals, Inc. $10,131 15 payments
  6. E.R. Squibb & Sons, L.L.C. $9,421 3 payments
  7. Celgene Corporation $272 7 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $183 3 payments
  9. Sanofi-Aventis U.S. LLC $115 1 payment
  10. QOL Medical, LLC $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $221,161 48 payments
  2. Consulting Fee $188,326 88 payments
  3. Travel and Lodging $19,291 72 payments
  4. Food and Beverage $4,201 73 payments
Products named General payments · program years 2020–2025
  1. DUPIXENT Immunology $159,057 80 payments
  2. DUPIXENT Inflammation And Immunology $143,967 118 payments
  3. DUPIXENT Immunology And Inflammation $18,398 17 payments
  4. TEZSPIRE $16,436 8 payments
  5. FASENRA $11,009 4 payments
  6. EOHILIA $61 2 payments
  7. Sucraid $26 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2020–2025
  1. Regeneron Pharmaceuticals, Inc. $1,705 3 payments

Records

284 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record